Latest News and Press Releases
Want to stay updated on the latest news?
-
DIMERx Appoints Lee S. Simon, MD as Chief Advisor for Clinical Development & Regulatory Strategy
-
6-month GLP-tox study reinforces favorable safety profile of Tiprelestat Phase II Study in Pulmonary Arterial Hypertension (PAH) to be initiated by Stanford University in mid-2026 Kiel, GERMANY,...
-
Vail, Colorado, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Steadman Philippon Research Institute (SPRI) has partnered with Neuromuscular Dynamics, LLC (NMD) to launch a clinical trial evaluating the...
-
BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Rendever, the company leading the industry in immersive technology for aging, has secured nearly $4.5 million in grant funding from the National Institutes...
-
SAN FRANCISCO, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The NIH has awarded a new grant to Posit Science, the maker of the online BrainHQ brain exercises, to advance research, which showed in a...
-
Watch the “What This Means” segment here MINNEAPOLIS, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company delivering fluid management solutions for...
-
VAIL, Colorado, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Steadman Philippon Research Institute (SPRI), in collaboration with the University of Texas Health Science Center at Houston (UTHealth), has...
-
- Novel, disease-modifying treatment option for Pulmonary Arterial Hypertension (PAH), an orphan indication with a significant unmet medical need Kiel, GERMANY, September 8, 2025 – tiakis Biotech AG...
-
SAN FRANCISCO, July 09, 2025 (GLOBE NEWSWIRE) -- DIMERx, Inc., a late-stage clinical biopharmaceutical company developing covalently bonded dimer therapeutics, today announced the appointment of...
-
SAN FRANCISCO, June 25, 2025 (GLOBE NEWSWIRE) -- DIMERx, Inc., a late-stage biopharmaceutical company entering growth phase, today announced it has been awarded a UG3/UH3 cooperative agreement...